Nvidia to Invest $1 Billion in AI Drug Lab With Eli Lilly

Nvidia to Invest $1 Billion in AI Drug Lab With Eli Lilly

Nvidia plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., in an effort to speed up the use of AI in the pharmaceutical industry. Denny Fish, portfolio manager on the Global Technology and Innovation Team at Janus Henderson Investors, joins Caroline Hyde and Ed Ludlo...

Redirecting to full article...